-
公开(公告)号:US5332750A
公开(公告)日:1994-07-26
申请号:US50800
申请日:1993-04-22
IPC分类号: C07D213/64 , C07D213/80 , C07D213/82 , C07D213/85 , C07D401/10 , C07D401/12 , C07D401/14 , A61K31/44 , C07D401/04
CPC分类号: C07D213/64 , C07D213/80 , C07D213/82 , C07D213/85 , C07D401/10 , C07D401/12 , C07D401/14
摘要: New 1,2-dihydro-2-oxopyridines of formula I ##STR1## in which R is the radical ##STR2## and R.sup.1 to R.sup.6 and X are as defined herein,and their salts, have antagonistic properties towards angiotensin II and can be used for the treatment of hypertension, aldosteronism and cardiac insufficiency.
摘要翻译: 式I的新1,2-二氢-2-氧代吡啶,其中R是基团,且R 1至R 6和X如本文所定义,并且其盐对血管紧张素II具有拮抗作用,并且可以是 用于治疗高血压,醛固酮增多和心功能不全。
-
公开(公告)号:US6037349A
公开(公告)日:2000-03-14
申请号:US224355
申请日:1999-01-04
申请人: Werner Mederski , Johannes Sombroek , Pierre Schelling , Norbert Beier , Ingeborg Lues , Klaus-Otto Minck
发明人: Werner Mederski , Johannes Sombroek , Pierre Schelling , Norbert Beier , Ingeborg Lues , Klaus-Otto Minck
IPC分类号: C07D471/04 , C07D471/02 , A61K31/415 , A61K31/44
CPC分类号: C07D471/04
摘要: Imidazopyridine derivatives ad pharmacologically acceptable salts having antagonistic properties towards angiotensin II can be used for the treatment of hypertension, aldosteronism and cardiac insufficiency.
摘要翻译: 具有拮抗血管紧张素II拮抗作用的药理学上可接受的盐的咪唑并吡啶衍生物可用于治疗高血压,醛固酮增多和心功能不全。
-
公开(公告)号:US5405964A
公开(公告)日:1995-04-11
申请号:US139668
申请日:1993-10-22
申请人: Werner Mederski , Dieter Dorsch , Andreas Bathe , Thorsten Hartig , Mathias Osswald , Norbert Beier , Pierre Schelling , Klaus-Otto Minck , Ingeborg Lues
发明人: Werner Mederski , Dieter Dorsch , Andreas Bathe , Thorsten Hartig , Mathias Osswald , Norbert Beier , Pierre Schelling , Klaus-Otto Minck , Ingeborg Lues
IPC分类号: A61K31/435 , A61K31/44 , A61P9/00 , A61P35/00 , A61P43/00 , C07D207/30 , C07D231/10 , C07D233/54 , C07D275/00 , C07D277/20 , C07D307/34 , C07D471/04 , C07D471/02 , C07D471/06
CPC分类号: C07D471/04
摘要: Novel imidazopyridine derivatives of formula I ##STR1## and X, --Y.dbd.Z--, R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 as defined herein, and their salts, exhibit antagonistic properties towards angiotensin II and can be used for the treatment of hypertension, aldosteronism, cardiac insufficiency and increased intraocular pressure, and of disorders of the central nervous system.
摘要翻译: 式I的新颖的咪唑并吡啶衍生物其中R为本文所定义的X为-Y = Z-,R1,R2,R3,R4和R5及其盐,对血管紧张素II表现出拮抗作用, 用于治疗高血压,醛固酮增多症,心功能不全和眼内压升高以及中枢神经系统疾病。
-
公开(公告)号:US5401738A
公开(公告)日:1995-03-28
申请号:US75247
申请日:1993-06-11
申请人: Werner Mederski , Dieter Dorsch , Norbert Beier , Pierre Schelling , Ingeborg Lues , Klaus-Otto Minck , Mathias Osswald
发明人: Werner Mederski , Dieter Dorsch , Norbert Beier , Pierre Schelling , Ingeborg Lues , Klaus-Otto Minck , Mathias Osswald
IPC分类号: A61K31/50 , A61K31/54 , A61P9/12 , A61P25/00 , A61P43/00 , C07D257/04 , C07D257/06 , C07D403/04 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/04 , C07D417/14 , C07D471/04 , C07D471/14 , C07D521/00
CPC分类号: C07D403/04 , C07D403/14 , C07D417/04 , C07D417/14
摘要: Benzimidazole compounds of the formula I ##STR1## and salts thereof, exhibit antagonistic properties toward angiotensin II and can be used for the treatment of hypertension, aldosteronism, cardiac insufficiency and an increased intraocular pressure, as well as disturbances of the central nervous system.
摘要翻译: 式I的苯并咪唑化合物及其盐对血管紧张素II表现出拮抗作用,可用于治疗高血压,醛固酮增多症,心功能不全,眼内压升高以及中枢神经系统紊乱。
-
公开(公告)号:US5371226A
公开(公告)日:1994-12-06
申请号:US31977
申请日:1993-03-16
申请人: Werner Mederski , Dieter Dorsch , Norbert Beier , Ingeborg Lues , Klaus-Otto Minck , Pierre Schelling
发明人: Werner Mederski , Dieter Dorsch , Norbert Beier , Ingeborg Lues , Klaus-Otto Minck , Pierre Schelling
IPC分类号: A61K31/47 , A61P9/00 , A61P9/12 , A61P43/00 , C07D215/22 , C07D215/227 , C07D215/54 , C07D401/06 , C07D401/10 , C07D401/14 , C07D413/06 , C07D413/14 , C07D215/48 , C07D215/50
CPC分类号: C07D215/227 , C07D401/10
摘要: 2-oxoquinoline derivative of formula I; ##STR1## wherein R is ##STR2## and R.sup.1 to R.sup.6 and X are as defined in claim 1, and their salts exhibit antagonistic properties towards angiotensin II and have inter alia a hypotensive action.
摘要翻译: 式I的2-氧代喹啉衍生物; 其中R为
且R 1至R 6和X如权利要求1中所定义,并且它们的盐对血管紧张素II表现出拮抗作用,尤其是具有降血压作用。 -
公开(公告)号:US4916128A
公开(公告)日:1990-04-10
申请号:US202294
申请日:1988-06-06
IPC分类号: A61K31/54 , A61K31/55 , A61P7/02 , A61P9/00 , A61P9/08 , C07D417/04 , C07D417/14
CPC分类号: C07D417/04 , C07D417/14
摘要: Thiadiazinones of the formula I ##STR1## wherein A is --CHR.sup.4 --CHR.sup.5 --, --CH.sub.2 --CR.sup.4 R.sup.5 --, --CR.sup.4 R.sup.5 --CH.sub.2 --, --CHR.sup.4 --CHR.sup.5 --CH.sub.2 --, --CHR.sup.4 --CH.sub.2 --CHR.sup.5 --, --CH.sub.2 --CHR.sup.4 --CHR.sup.5 --, --CR.sup.4 R.sup.5 --CH.sub.2 CH.sub.2 --, --CH.sub.2 --CR.sup.4 R.sup.5 --CH.sub.2 -- or --CH.sub.2 CH.sub.2 --CR.sup.4 R.sup.5 --,R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are each independently H, C.sub.1-5 -alkyl, C.sub.2-5 -alkenyl or C.sub.2-5 -alkinyl,R.sup.3 is also C.sub.1-15 -acyl,R.sup.6 is H, alkyl, alkoxyl, OH, F, Cl, Br or I andZ is (H, H), (H, alkyl), (alkyl, alkyl) or O,the alkyl, alkenyl, alkinyl and/or alkoxy groups in each case containing up to 5 C atoms, but wherein, if A is --CH.sub.2 CH.sub.2 -- and Z is O, one of the radicals R.sup.1, R.sup.2, R.sup.3 and R.sup.6 must be other than H,and salts thereof demonstrate positive inotropic action and are suitable for combating cardiovascular diseases.
摘要翻译: 其中A是-CHR 4 -CHR 5 - , - CH 2 - CR 4 R 5 - , - CR 4 R 5 -CH 2 - , - CHR 4 -CHR 5 -CH 2 - , - CHR 4 -CH 2 - CHR 5 - , - CH 2 CHR 4 - CHR5-,-CR4R5-CH2CH2-,-CH2-CR4R5-CH2-或-CH2CH2-CR4R5-,R1,R2,R3,R4和R5各自独立地为H,C1-5烷基,C2-5-烯基或C2 -5-炔基,R 3还为C 1-15酰基,R 6为H,烷基,烷氧基,OH,F,Cl,Br或I,Z为(H,H),(H,烷基) )或O,每种情况下的烷基,烯基,炔基和/或烷氧基含有至多5个C原子,但其中,如果A是-CH 2 CH 2 - 并且Z是O,基团R 1,R 2,R 3和R 6中的一个 必须不是H,其盐表现出正性肌力作用,并且适用于对抗心血管疾病。
-
公开(公告)号:US5013853A
公开(公告)日:1991-05-07
申请号:US347710
申请日:1989-05-05
IPC分类号: A61K31/44 , A61K31/443 , A61K31/495 , A61K31/50 , A61K31/505 , A61P9/00 , A61P9/12 , A61P11/00 , A61P13/02 , A61P15/00 , A61P21/02 , C07D311/22 , C07D405/04 , C07D405/10 , C07D405/12 , C07D405/14 , C07D493/04
CPC分类号: C07D405/04 , C07D311/22 , C07D405/10 , C07D405/12 , C07D405/14 , C07D493/04
摘要: A compound of the formula: ##STR1## where in x-y is --CO--CH.sub.2 --, --COCR.sup.10-, --CHOHCHR.sup.8-, --CH.dbd.CR.sup.8 -- or ##STR2## and R.sup.9 is various, R.sup.1 and R.sup.8 are alkyl, R.sub.2 is H or alkyl and R.sup.1 and R.sup.2 are alkylene, are disclosed as useful as intermediates for cardiovascular agents.
摘要翻译: 下式的化合物:其中在xy是-CO-CH 2 - ,-COCR 10 - , - CHOHCHR 8 - , - CH = CR 8 - 或
和R 9是各种,R 1和R 8是烷基,R 2是H 或烷基,R 1和R 2为亚烷基,可用作心血管药物的中间体。 -
公开(公告)号:US5130322A
公开(公告)日:1992-07-14
申请号:US562542
申请日:1990-08-03
IPC分类号: C07D311/22 , A61K31/35 , A61K31/352 , A61K31/40 , A61K31/44 , A61K31/443 , A61K31/50 , A61P9/08 , A61P9/10 , A61P25/02 , C07D311/58 , C07D311/68 , C07D405/04 , C07D405/12 , C07D493/04
CPC分类号: C07D405/04
摘要: The invention relates to chroman derivatives of the formula I ##STR1## in which R.sup.1 is A,R.sup.2 is OA,R.sup.3 is OH,R.sup.4 is H, orR.sup.3 and R.sup.4 together are a bond,R.sup.5 is a 2-oxo-1,2-dihydro-1-pyridyl or 2-oxo-2,3-dihydro-4-pyrodyl radical which is optionally monosubstituted by A,R.sup.6 is CN,R.sup.7 and R.sup.8 are each H,Z is O, NH or a bond, andA is alkyl having 1-6 C atoms,or a physiologically acceptable salt thereof.
摘要翻译: 本发明涉及式Ⅰ的苯并二氢吡喃衍生物,其中R1是A,R2是OA,R3是OH,R4是H,或R3和R4同时是一个键,R5是2-氧代-1, 任选被A,R6单取代的2-二氢-1-吡啶基或2-氧代-2,3-二氢-4-烟酰基是CN,R 7和R 8各自为H,Z为O,NH或键,并且 A是具有1-6个C原子的烷基,或其生理上可接受的盐。
-
公开(公告)号:US5112839A
公开(公告)日:1992-05-12
申请号:US549043
申请日:1990-07-06
IPC分类号: A61K31/35 , A61K31/44 , A61K31/443 , A61P9/12 , A61P25/02 , C07D405/04
CPC分类号: C07D405/04
摘要: Novel chroman derivatives of the formula I ##STR1## in which R.sup.1 to R.sup.10 have the meanings given in patent claim 1, and their salts show effects on the cardiovascular system and can be used for the treatment or prophylaxis of cardiac insufficiency, angina pectoris, high blood pressure, incontinence and alopecia.
摘要翻译: R1至R10具有权利要求1中给出的含义的式I
的新型苯并二氢吡喃衍生物及其盐显示对心血管系统的作用,可用于治疗或预防心功能不全,心绞痛,高 血压,失禁和脱发。 -
公开(公告)号:US5132307A
公开(公告)日:1992-07-21
申请号:US432836
申请日:1989-11-07
IPC分类号: C07D237/14 , A61K31/44 , A61K31/4402 , A61K31/4412 , A61K31/4418 , A61K31/4425 , A61K31/495 , A61K31/50 , A61K31/505 , A61P9/06 , A61P9/12 , A61P11/00 , A61P17/00 , C07D207/38 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/74 , C07D237/16 , C07D237/18 , C07D237/24 , C07D239/36 , C07D239/54 , C07D241/18
CPC分类号: C07D213/69 , C07D213/64 , C07D213/70 , C07D213/74 , C07D237/16 , C07D237/18
摘要: New tetralin derivatives of the formula I ##STR1## wherein R.sup.1 to R.sup.8 and Z have the meanings indicated herein and salts thereof, exhibit an effect on the cardiovascular system.
摘要翻译: 式Ⅰ的新的四氢化萘衍生物,其中R1至R8和Z具有本文所述的含义及其盐,对心血管系统表现出影响。
-
-
-
-
-
-
-
-
-